Will Robinhood Stock Keep Going Up?
Commission-free online brokerage Robinhood (NASDAQ:HOOD) has served up massive gains…
Sell
26
ELVN Quote, Financials, Valuation and Earnings
Last price:
$20.68
Seasonality move
:
-4.5%
Day range:
$19.74 - $21.29
52-week range:
$13.30 - $30.03
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
3.51x
Volume:
947K
Avg. volume:
618.9K
1-year change:
-4.88%
Market cap:
$1B
Revenue:
--
EPS (TTM):
-$1.92
Earnings Data
Next earnings date for ELVN
Aug 13
2025
Most recent earnings per share
-$0.57
Missed by $0.57
(May 14/2025)
Consensus Estimate
--
(May 14/2025)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
ELVN Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 09/30/2025 | Q3 | -- | -- | -- | -$0.44 | -- |
| 08/13/2025 | Q2 | -- | -- | -- | -$0.42 | -- |
| 05/14/2025 | Q1 | -- | -- | -$0.57 | -- | -- |
| 03/13/2025 | Q4 | -- | -- | -$0.46 | -- | -- |
| 11/13/2024 | Q3 | -- | -- | -$0.48 | -$0.50 | $0.02 |
| 08/13/2024 | Q2 | -- | -- | -$0.41 | -- | -- |
| 05/14/2024 | Q1 | -- | -- | -$0.54 | -- | -- |
| 03/14/2024 | Q4 | -- | -- | -$0.46 | -- | -- |
| 11/09/2023 | Q3 | -- | -- | -$0.51 | -- | -- |
| 08/10/2023 | Q2 | -- | -- | -$0.41 | -- | -- |
| 05/11/2023 | Q1 | -- | -- | -$0.80 | -- | -- |
| 12/31/2022 | Q4 | -- | -- | -$0.23 | -- | -- |
| 09/30/2022 | Q3 | -- | -- | -$0.26 | -- | -- |
| 06/30/2022 | Q2 | -- | -- | -$0.22 | -- | -- |
| 03/31/2022 | Q1 | -- | -- | -$0.21 | -- | -- |
| 12/31/2021 | Q4 | -- | -- | -$0.20 | -- | -- |
Enliven Therapeutics Earnings Questions
-
How Much did Enliven Therapeutics Generate in Revenue Last Quarter?
Enliven Therapeutics reported -- worth of top line sales in its most recent quarter.
-
Did Enliven Therapeutics Beat Earnings Last Quarter?
Enliven Therapeutics announced earnings per share of -$0.57 which represents a miss of analyst forecast a -- per share.
-
Is Enliven Therapeutics Profitable?
Enliven Therapeutics reported -- that represents -- per share over the last quarter.
-
What is the Analyst Consensus for Enliven Therapeutics EPS Next Year?
Enliven Therapeutics's earnings are forecast to decrease from -$1.89 per share to -$1.59 per share next year representing a decrease of -13.23%.
-
When is Enliven Therapeutics's Earnings Date?
Enliven Therapeutics's next earnings date is August 13, 2025.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Where Will Hershey Stock Be In 1 Year?
Chocolate stocks used to be the epitome of sleepy stability,…
Where Will KNOT Stock Be In 1 Year?
In the case of KNOT Offshore Partners (KNOP), most headlines…
Stock Ideas
Buy
63
Is NVDA Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 53x
Buy
60
Is MSFT Stock a Buy?
Market Cap: $3.7T
P/E Ratio: 42x
Sell
48
Is AAPL Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 35x
Alerts
Buy
92
BGL alert for Jul 3
Blue Gold [BGL] is down 20.3% over the past day.
Sell
18
CNC alert for Jul 3
Centene [CNC] is down 1.3% over the past day.
Sell
12
MOH alert for Jul 3
Molina Healthcare [MOH] is up 0.3% over the past day.
